EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY

Cyclosporine

FDA Premarket Approval P920031 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for emit(r) cyclosporine sample pretreatment reagent and cobas integra 700 cyclosporine.

DeviceEMIT 2000 CYCLOSPORINE SPECIFIC ASSAY
Classification NameCyclosporine
Generic NameCyclosporine
ApplicantDADE BEHRING, INC.
Date Received1999-07-02
Decision Date2000-08-11
PMAP920031
SupplementS001
Product CodeMKW
Advisory CommitteeToxicology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address DADE BEHRING, INC. po Box 6101 newark, DE 19714-6101

Supplemental Filings

Supplement NumberDateSupplement Type
P920031Original Filing
S003 2002-05-17 Normal 180 Day Track
S002 2002-02-20 Real-time Process
S001 1999-07-02 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
00842768001475 P920031 000
00842768001468 P920031 000
00842768001482 P920031 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.